HIV moments and pre-exposure prophylaxis Robert M Grant, David V Glidden The Lancet Volume 387, Issue 10027, Pages 1507-1508 (April 2016) DOI: 10.1016/S0140-6736(16)30125-8 Copyright © 2016 Elsevier Ltd Terms and Conditions
Figure Temporal variation in sexual practices involving HIV risk Each row represents one person who seroconverted in the placebo group of the iPrEx trial of pre-exposure prophylaxis in men who have sex with men and transgender women. Non-condom receptive anal intercourse was reported most frequently at enrolment, and sporadically thereafter. The Lancet 2016 387, 1507-1508DOI: (10.1016/S0140-6736(16)30125-8) Copyright © 2016 Elsevier Ltd Terms and Conditions